ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2022
[Effect and safety of pegylated recombinant human G-CSF on hematopoietic reconstitution after autologous hematopoietic stem cell transplantation in lymphoma patients].
Y G Shen, M M Ji, Z Zheng, W Tang, W L Zhao
Open access · greenAbstract readEnglish Abstract
In one paragraphArticle in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors at 3 institutions in 1 country.
Y G ShenShanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
M M JiShanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Z ZhengShanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
W TangShanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
W L ZhaoShanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Shanghai Institute of Hematology · CNShanghai Jiao Tong University · CNRuijin Hospital · CN
Funding
Clinical Research Plan of Shanghai Hospital Development Center SHDC2020CR1032BKey Project of National Natural Science Foundation of China 82130004
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
AgranulocytosisHematopoietic Stem Cell TransplantationLymphomaChinaGranulocyte Colony-Stimulating FactorHumansPolyethylene GlycolsRecombinant ProteinsTransplantation, AutologousGranulocyte Colony-Stimulating FactorPolyethylene GlycolsRecombinant ProteinsAutologous stem cell transplantationLymphomaPegylated Recombinant human colony-stimulating factorRecombinant human colony-stimulating factor
Identifiers
PMID36709186
PMCPMC9808863
OpenAlexW4318450543
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390